Search Results - "HALEY, JOHN D."

Refine Results
  1. 1

    Kinetics and Mechanism of Mammalian Mitochondrial Ribosome Assembly by Bogenhagen, Daniel F., Ostermeyer-Fay, Anne G., Haley, John D., Garcia-Diaz, Miguel

    Published in Cell reports (Cambridge) (13-02-2018)
    “…Mammalian mtDNA encodes only 13 proteins, all essential components of respiratory complexes, synthesized by mitochondrial ribosomes. Mitoribosomes contain…”
    Get full text
    Journal Article
  2. 2

    Podocyte-specific KLF6 primes proximal tubule CaMK1D signaling to attenuate diabetic kidney disease by Gujarati, Nehaben A., Frimpong, Bismark O., Zaidi, Malaika, Bronstein, Robert, Revelo, Monica P., Haley, John D., Kravets, Igor, Guo, Yiqing, Mallipattu, Sandeep K.

    Published in Nature communications (13-09-2024)
    “…Diabetic kidney disease (DKD) is the main cause of chronic kidney disease worldwide. While injury to the podocytes, visceral epithelial cells that comprise the…”
    Get full text
    Journal Article
  3. 3

    Zng1 is a GTP-dependent zinc transferase needed for activation of methionine aminopeptidase by Pasquini, Miriam, Grosjean, Nicolas, Hixson, Kim K., Nicora, Carrie D., Yee, Estella F., Lipton, Mary, Blaby, Ian K., Haley, John D., Blaby-Haas, Crysten E.

    Published in Cell reports (Cambridge) (17-05-2022)
    “…The evolution of zinc (Zn) as a protein cofactor altered the functional landscape of biology, but dependency on Zn also created an Achilles’ heel,…”
    Get full text
    Journal Article
  4. 4

    The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer by Eyermann, Christopher E., Haley, John D., Alexandrova, Evguenia M.

    Published in Cell death & disease (26-01-2021)
    “…Breast cancer is the leading cause of cancer-related death in women worldwide. Human epidermal growth factor receptor 2 (HER2)-positive subtype comprises 20%…”
    Get full text
    Journal Article
  5. 5

    Integrative multi-omics profiling reveals cAMP-independent mechanisms regulating hyphal morphogenesis in Candida albicans by Min, Kyunghun, Jannace, Thomas F, Si, Haoyu, Veeramah, Krishna R, Haley, John D, Konopka, James B

    Published in PLoS pathogens (16-08-2021)
    “…Microbial pathogens grow in a wide range of different morphologies that provide distinct advantages for virulence. In the fungal pathogen Candida albicans ,…”
    Get full text
    Journal Article
  6. 6

    Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy by Thomson, Stuart, Petti, Filippo, Sujka-Kwok, Izabela, Epstein, David, Haley, John D.

    Published in Clinical & experimental metastasis (01-12-2008)
    “…NSCLC cells with a mesenchymal phenotype have shown a marked reduction in sensitivity to EGFR inhibitors, though the molecular rationale has remained obscure…”
    Get full text
    Journal Article
  7. 7

    Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages by Wang, Daifeng, Haley, John D, Thompson, Patricia

    Published in BMC cancer (06-12-2017)
    “…The epithelial to mesenchymal transition (EMT) plays a key role in lung cancer progression and drug resistance. The dynamics and stability of gene expression…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Novel replisome-associated proteins at cellular replication forks in EBV-transformed B lymphocytes by Xu, Huanzhou, Perez, Ramon D, Frey, Tiffany R, Burton, Eric M, Mannemuddhu, Sudha, Haley, John D, McIntosh, Michael T, Bhaduri-McIntosh, Sumita

    Published in PLoS pathogens (01-12-2019)
    “…Epstein-Barr virus (EBV) is an oncogenic herpesvirus and WHO class 1 carcinogen that resides in B lymphocytes of nearly all humans. While silent in most, EBV…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non–small-cell lung, pancreatic, colon, and breast tumors by Buck, Elizabeth, Eyzaguirre, Alexandra, Brown, Eric, Petti, Filippo, McCormack, Siobhan, Haley, John D, Iwata, Kenneth K, Gibson, Neil W, Griffin, Graeme

    Published in Molecular cancer therapeutics (01-11-2006)
    “…The receptor for epidermal growth factor (EGFR) is overexpressed in many cancers. One important signaling pathway regulated by EGFR is the phosphatidylinositol…”
    Get full text
    Journal Article
  14. 14

    AACR Special Conference on Epithelial-Mesenchymal Transition and Cancer Progression and Treatment by ROUSSOS, Evanthia T, KECKESOVA, Zuzana, HALEY, John D, EPSTEIN, David M, WEINBERG, Robert A, CONDEELIS, John S

    Published in Cancer research (Chicago, Ill.) (01-10-2010)
    “…Epithelial-mesenchymal transition (EMT) is a developmental program implicated in cancer progression and was the subject of the 2010 AACR meeting on the topic…”
    Get full text
    Journal Article
  15. 15

    Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition by Buck, Elizabeth, Eyzaguirre, Alexandra, Barr, Sharon, Thompson, Stuart, Sennello, Regina, Young, David, Iwata, Kenneth K, Gibson, Neil W, Cagnoni, Pablo, Haley, John D

    Published in Molecular cancer therapeutics (01-02-2007)
    “…Overexpression and enhanced activation of the epidermal growth factor receptor (EGFR) is frequently observed in human carcinomas. Inhibitors of EGFR signaling…”
    Get full text
    Journal Article
  16. 16

    Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer by Hwang, Ga-Ram, Yuen, John G., Fesler, Andrew, Farley, Hannah, Haley, John D., Ju, Jingfang

    Published in Molecular therapy. Oncolytics (16-03-2023)
    “…Lung cancer is the leading cause of cancer-related deaths in the United States with non-small cell lung cancer (NSCLC) accounting for most cases. Despite…”
    Get full text
    Journal Article
  17. 17

    Mass Spectrometry and Pharmacological Approaches to Measuring Cooption and Reciprocal Activation of Receptor Tyrosine Kinases by Linzer, Jason, Phelps, Zachary, Vummidi, Shivasuryan, Lee, Bo Young Elizabeth, Coant, Nicolas, Haley, John D

    Published in Proteomes (01-06-2023)
    “…Receptor tyrosine kinases (RTKs) can show extensive crosstalk, directly and indirectly. Elucidating RTK crosstalk remains an important goal in the clinical…”
    Get full text
    Journal Article
  18. 18

    Inactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to erlotinib sensitivity by Buck, Elizabeth, Eyzaguirre, Alexandra, Haley, John D, Gibson, Neil W, Cagnoni, Pablo, Iwata, Kenneth K

    Published in Molecular cancer therapeutics (01-08-2006)
    “…Signaling through the receptor for epidermal growth factor receptor (EGFR) is frequently deregulated in solid tumors. Erlotinib (Tarceva, OSI-774, OSI…”
    Get full text
    Journal Article
  19. 19

    Inhibition of phosphoenolpyruvate carboxykinase blocks lactate utilization and impairs tumor growth in colorectal cancer by Montal, Emily D, Bhalla, Kavita, Dewi, Ruby E, Ruiz, Christian F, Haley, John A, Ropell, Ashley E, Gordon, Chris, Haley, John D, Girnun, Geoffrey D

    Published in Cancer & metabolism (01-08-2019)
    “…Metabolic reprogramming is a key feature of malignant cells. While glucose is one of the primary substrates for malignant cells, cancer cells also display a…”
    Get full text
    Journal Article
  20. 20

    Phosphotyrosine Signaling Networks in Epidermal Growth Factor Receptor Overexpressing Squamous Carcinoma Cells by Thelemann, April, Petti, Filippo, Griffin, Graeme, Iwata, Ken, Hunt, Tony, Settinari, Tina, Fenyo, David, Gibson, Neil, Haley, John D

    Published in Molecular & cellular proteomics (01-04-2005)
    “…Overexpression and enhanced activation of the epidermal growth factor (EGF) receptor are frequent events in human cancers that correlate with poor prognosis…”
    Get full text
    Journal Article